{"id":45789,"date":"2022-07-04T19:01:33","date_gmt":"2022-07-04T17:01:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/"},"modified":"2022-07-04T19:01:33","modified_gmt":"2022-07-04T17:01:33","slug":"global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/","title":{"rendered":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2987374\/global-bioinformatics-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vb4zns&amp;utm_campaign=1721577+-+Global+Bioinformatics+Partnering+Terms+and+Agreements+2015+to+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Bioinformatics Partnering Terms and Agreements 2015 to 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.\n<\/p>\n<ul>\n<li>\nTrends in bioinformatics partnering deals\n<\/li>\n<li>\nPartnering agreement structure\n<\/li>\n<li>\nPartnering contract documents\n<\/li>\n<li>\nTop deals by value\n<\/li>\n<li>\nMost active deal makers\n<\/li>\n<li>\nFinancial deal terms for bioinformatics\n<\/li>\n<\/ul>\n<p>\nThe Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.\n<\/p>\n<p>\nThe report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborative R&amp;D, and commercialization of outcomes.\n<\/p>\n<p>\nThis report provides details of the latest bioinformatics agreements announced in the healthcare sectors.\n<\/p>\n<p>\nBioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order to speed up the discovery, evaluation and clinical assessment processes.\n<\/p>\n<p>\nUnderstanding the flexibility of a prospective partner&#8217;s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered &#8211; contract documents provide this insight where press releases and databases do not.\n<\/p>\n<p>\nThis report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2015, including financial terms where available, including over 1600 links to online deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in bioinformatics dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Bioinformatics partnering over the years\n<\/p>\n<p>\n2.3. Most active bioinformatics dealmakers\n<\/p>\n<p>\n2.4. Bioinformatics partnering by deal type\n<\/p>\n<p>\n2.5. Bioinformatics partnering by therapy area\n<\/p>\n<p>\n2.6. Deal terms for bioinformatics partnering\n<\/p>\n<p>\n2.6.1 Bioinformatics partnering headline values\n<\/p>\n<p>\n2.6.2 Bioinformatics deal upfront payments\n<\/p>\n<p>\n2.6.3 Bioinformatics deal milestone payments\n<\/p>\n<p>\n2.6.4 Bioinformatics royalty rates\n<\/p>\n<p>\n<strong>Chapter 3 &#8211; Leading bioinformatics deals<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Top bioinformatics deals by value\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Most active bioinformatics dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active bioinformatics dealmakers\n<\/p>\n<p>\n4.3. Most active bioinformatics partnering company profiles\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Bioinformatics contracts dealmaking directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Bioinformatics contracts dealmaking directory\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Bioinformatics dealmaking by technology type<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n1QBit\n<\/li>\n<li>\n2bPrecise\n<\/li>\n<li>\n3B Medical\n<\/li>\n<li>\n3D Signatures\n<\/li>\n<li>\n3D Systems\n<\/li>\n<li>\n3M\n<\/li>\n<li>\n4HF Biotec\n<\/li>\n<li>\n10X Genomics\n<\/li>\n<li>\n23andMe\n<\/li>\n<li>\n111\n<\/li>\n<li>\n121nexus\n<\/li>\n<li>\nA2A Pharmaceuticals\n<\/li>\n<li>\nA3 Informatics\n<\/li>\n<li>\nAbarca\n<\/li>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAbbvie\n<\/li>\n<li>\nAbramson Cancer Center\n<\/li>\n<li>\nAbyde\n<\/li>\n<li>\nAcademic Medical Center\n<\/li>\n<li>\nAccelerated Enrollment Solutions\n<\/li>\n<li>\nAccelq\n<\/li>\n<li>\nAccenture\n<\/li>\n<li>\nAccessDx Laboratory\n<\/li>\n<li>\nAccuray\n<\/li>\n<li>\nAccuWeather\n<\/li>\n<li>\nAcentrus Specialty\n<\/li>\n<li>\nAchilles Therapeutics\n<\/li>\n<li>\nActigraph\n<\/li>\n<li>\nActive Motif\n<\/li>\n<li>\nActX\n<\/li>\n<li>\nAcuant\n<\/li>\n<li>\nAcumen Analytics\n<\/li>\n<li>\nAcurian\n<\/li>\n<li>\nAdapt Analytics\n<\/li>\n<li>\nAdaptiiv\n<\/li>\n<li>\nAdaptive Biotechnologies\n<\/li>\n<li>\nAdaptive Research\n<\/li>\n<li>\nADAS 3D Medical\n<\/li>\n<li>\nAdents\n<\/li>\n<li>\nAdhera Therapeutics\n<\/li>\n<li>\nAdhereHealth\n<\/li>\n<li>\nAditx Therapeutics\n<\/li>\n<li>\nAdracare\n<\/li>\n<li>\nAdvaita\n<\/li>\n<li>\nAdvanced Biological Laboratories\n<\/li>\n<li>\nAdvanced Clinical\n<\/li>\n<li>\nAdvanced Guidance Technologies\n<\/li>\n<li>\nAdvanced Radiation Therapy\n<\/li>\n<li>\nAdvantech\n<\/li>\n<li>\nAdvarra\n<\/li>\n<li>\nAdvocate Health Care\n<\/li>\n<li>\nAether\n<\/li>\n<li>\nAetion\n<\/li>\n<li>\nAetna\n<\/li>\n<li>\nAetos Pharma\n<\/li>\n<li>\nAevolve\n<\/li>\n<li>\nAgadia Systems\n<\/li>\n<li>\nAgaMatrix\n<\/li>\n<li>\nAgileBio\n<\/li>\n<li>\nAgilent Technologies\n<\/li>\n<li>\nAG Mednet\n<\/li>\n<li>\nAiCure\n<\/li>\n<li>\nAidoc\n<\/li>\n<li>\nAiforia Technologies\n<\/li>\n<li>\nAirXpanders\n<\/li>\n<li>\nAIT Laboratories\n<\/li>\n<li>\nAkerna\n<\/li>\n<li>\nAkili Interactive Labs\n<\/li>\n<li>\nAlector\n<\/li>\n<li>\nAlexion Pharmaceuticals\n<\/li>\n<li>\nAlex Therapeutics\n<\/li>\n<li>\nAlibaba Health\n<\/li>\n<li>\nAlienware\n<\/li>\n<li>\nAlira Health\n<\/li>\n<li>\nAlit Life Science\n<\/li>\n<li>\nAlkahest\n<\/li>\n<li>\nAllelica\n<\/li>\n<li>\nAllergan\n<\/li>\n<li>\nAlliance for Clinical Research Excellence and Safety (ACRES)\n<\/li>\n<li>\nAlliance For Clinical Trials In Oncology\n<\/li>\n<li>\nAllosteric Bioscience\n<\/li>\n<li>\nAllotrope Foundation\n<\/li>\n<li>\nAllscripts\n<\/li>\n<li>\nAllyAlign Health\n<\/li>\n<li>\nAlmac Group\n<\/li>\n<li>\nAlmirall\n<\/li>\n<li>\nALS Association\n<\/li>\n<li>\nAltMed Florida\n<\/li>\n<li>\nAltoida\n<\/li>\n<li>\nAlto Neuroscience\n<\/li>\n<li>\nAlvarado Hospital Medical Center\n<\/li>\n<li>\nAlyvant\n<\/li>\n<li>\nAlzheimer&#8217;s Drug Discovery Foundation\n<\/li>\n<li>\nAmazon Web Services\n<\/li>\n<li>\nAmber Pharmacy\n<\/li>\n<li>\nAmerican Academy of Neurology\n<\/li>\n<li>\nAmerican Cancer Society\n<\/li>\n<li>\nAmerican College of Cardiology\n<\/li>\n<li>\nAmerican Diabetes Association\n<\/li>\n<li>\nAmerican Heart Association\n<\/li>\n<li>\nAmerican Medical Association\n<\/li>\n<li>\nAmerican National Multiple Sclerosis Society\n<\/li>\n<li>\nAmerican Sleep Apnea Association\n<\/li>\n<li>\nAmerican Society of Hematology\n<\/li>\n<li>\nAmerican Speech-Language-Hearing Association\n<\/li>\n<li>\nAmerican Type Culture Collection (ATCC)\n<\/li>\n<li>\nAmerican Well\n<\/li>\n<li>\nAmerinet\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nAmici Pharmaceuticals\n<\/li>\n<li>\nAmplifire\n<\/li>\n<li>\nAMRA\n<\/li>\n<li>\nAmylyx Pharmaceuticals\n<\/li>\n<li>\nAmyris\n<\/li>\n<li>\nAnalytical BioSciences\n<\/li>\n<li>\nAncestry\n<\/li>\n<li>\nAnchorDx\n<\/li>\n<li>\nAndelyn Biosciences\n<\/li>\n<li>\nAndor Technology\n<\/li>\n<li>\nAndrew Alliance\n<\/li>\n<li>\nAnelto\n<\/li>\n<li>\nAnju Software\n<\/li>\n<li>\nAnnum Health\n<\/li>\n<li>\nANP Technologies\n<\/li>\n<li>\nAntengene\n<\/li>\n<li>\nAnthem\n<\/li>\n<li>\nAnthroTronix\n<\/li>\n<li>\nAO Foundation\n<\/li>\n<li>\nApollo Health\n<\/li>\n<li>\nApollo Healthcare\n<\/li>\n<li>\nAppBus\n<\/li>\n<li>\nAppian Labs\n<\/li>\n<li>\nAppistry\n<\/li>\n<li>\nApple\n<\/li>\n<li>\nApplied BioMath\n<\/li>\n<li>\nApplied DNA Sciences\n<\/li>\n<li>\nAppliedVR\n<\/li>\n<li>\nAppriss Health\n<\/li>\n<li>\nApricity Health\n<\/li>\n<li>\nAprima Medical Software\n<\/li>\n<li>\nAptar Pharma\n<\/li>\n<li>\nArbor Biotechnologies\n<\/li>\n<li>\nARCA Biopharma\n<\/li>\n<li>\nArc Bio\n<\/li>\n<li>\nArcherDX\n<\/li>\n<li>\nAres Genetics\n<\/li>\n<li>\nArgent Development Group\n<\/li>\n<li>\nAriana Pharma\n<\/li>\n<li>\nAris Global\n<\/li>\n<li>\nArisGlobal\n<\/li>\n<li>\nArivis\n<\/li>\n<li>\nArm\n<\/li>\n<li>\nArmor\n<\/li>\n<li>\nArria\n<\/li>\n<li>\nArtificial\n<\/li>\n<li>\nAscenion\n<\/li>\n<li>\nAscensia Diabetes Care\n<\/li>\n<li>\nASH Research Collaborative\n<\/li>\n<li>\nAsimily\n<\/li>\n<li>\nAspen Imaging Healthcare\n<\/li>\n<li>\nAstellas Pharma\n<\/li>\n<li>\nAstraZeneca\n<\/li>\n<li>\nAthenahealth\n<\/li>\n<li>\nATMPS\n<\/li>\n<li>\nAtomwise\n<\/li>\n<li>\nATUM\n<\/li>\n<li>\nAudaire Health\n<\/li>\n<li>\nAural Analytics\n<\/li>\n<li>\nAuria Biobank\n<\/li>\n<li>\nAurochs\n<\/li>\n<li>\nAutism Learning Partners\n<\/li>\n<li>\nAutolomous\n<\/li>\n<li>\nAutomation Anywhere\n<\/li>\n<li>\nAuxita\n<\/li>\n<li>\nAvalere Health\n<\/li>\n<li>\nAvera Health\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2987374\/global-bioinformatics-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vb4zns&amp;utm_campaign=1721577+-+Global+Bioinformatics+Partnering+Terms+and+Agreements+2015+to+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/8p713j<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x70;&#x72;e&#115;&#115;&#x40;&#x72;e&#115;&#x65;&#x61;&#x72;c&#104;&#x61;&#x6e;d&#109;&#97;&#x72;&#x6b;e&#116;&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#x72;&#x65;s&#101;&#97;&#x72;&#x63;h&#97;&#x6e;&#x64;m&#97;&#x72;&#x6b;e&#116;&#115;&#x2e;&#x63;o&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bioinformatics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45789","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bioinformatics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-04T17:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-04T17:01:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/\"},\"wordCount\":827,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220704005359\\\/en\\\/1504142\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/\",\"name\":\"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220704005359\\\/en\\\/1504142\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-04T17:01:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220704005359\\\/en\\\/1504142\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220704005359\\\/en\\\/1504142\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bioinformatics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-04T17:01:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-07-04T17:01:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/"},"wordCount":827,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/","name":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg","datePublished":"2022-07-04T17:01:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220704005359\/en\/1504142\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-bioinformatics-partnering-terms-and-agreements-2015-to-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45789"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45789\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}